First Time Loading...

Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 10.1 USD -1.37% Market Closed
Updated: May 9, 2024

Phathom Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Phathom Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Pre-Tax Income
-$201.6m
CAGR 3-Years
-16%
CAGR 5-Years
-175%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Pre-Tax Income
$20.1B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Pre-Tax Income
-$5.8B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Pre-Tax Income
-$1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Pre-Tax Income
$3.9B
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
Eli Lilly and Co
NYSE:LLY
Pre-Tax Income
$7.6B
CAGR 3-Years
2%
CAGR 5-Years
20%
CAGR 10-Years
5%

See Also

What is Phathom Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-201.6m USD

Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Pre-Tax Income amounts to -201.6m USD.

What is Phathom Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-175%

Over the last year, the Pre-Tax Income growth was -2%. The average annual Pre-Tax Income growth rates for Phathom Pharmaceuticals Inc have been -16% over the past three years , -175% over the past five years .